Phase I trial of OTS11101, an anti‐angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor
暂无分享,去创建一个
Kaoru Tanaka | K. Nishio | T. Satoh | T. Tsunoda | K. Nakagawa | T. Kurata | M. Takeda | Y. Fujisaka | T. Okabe | T. Arao | H. Hayashi | Koji Yoshida | H. Kawakami